Become a leading technological and innovative pharmaceutical enterprise

Shandong Yumankun Biotechnology Co., Ltd.

Shandong Yumankun Biotechnology Co., Ltd. was established in June 2018.It is a national high-tech enterprise, Shandong Province gazelle enterprise, science and technology-based small and medium-sized enterprises, provincial specialties and new small and medium-sized enterprises and has passed ISO9001 quality management system certification.

Company is committed to the research and development of new drugs and high-tech development of medicine. Since its establishment, it has completed more than 30 scientific and technological achievements transformation, and has many varieties of generic drugs covering high-tech barriers, second-class new drugs and a variety of improved and innovative drugs. Its varieties cover neurology, respiratory, nephrology, gastroenterology and other fields. With more than 3000 square meters of R & D center, it is expected that in the next 3 to 5 years, the company will build a pharmaceutical innovation base integrating R & D, investment and operation. In early 2021, the company signed a capital increase and share expansion cooperation agreement with Shandong Kangmeile Pharmaceutical Technology Co., Ltd., accounting for 60% of the shares. Shandong kangmeile pharmaceutical technology co., ltd. has a laboratory area of 3200 square meters. it is Jinan's 5150 talent enterprise, overseas student enterprise, national high-tech enterprise, specialized and special new enterprise. it is listed on the science and technology board of Qilu equity trading center (stock code 172007). it is ahead of the new drug research and development industry through ISO9001 quality system certification, intellectual property management system certification, and SOP management in the whole research and development process.

The company has a full service system from project research, synthesis process development, impurity preparation, preparation research, quality research, stability research, registration application to obtaining drug registration certificate and production technology guidance.

Enterprise Mission

Focus on Medical Technology and Seec Health for the Public

corporate mission is the foundation of the company, which explains the value and significance of the company's existence; the company always regards drug research and development as the supporting force for the sustainable development of the company, integrates the resources of the entire industry chain in research and development innovation, and cooperates with medical institutions of higher learning and national Many scientific research institutions such as key drug laboratories cooperate to develop new products, and have established long-term industry-university-research cooperation relationships with many well-known pharmaceutical companies to ensure continuous innovative products, the company also has a strict product quality management and control system, product quality is the lifeline of the company's survival and development, in order to ensure the efficacy and safety of drugs, our company implements strict quality audit and assessment, and comprehensively improves the qualified rate of products leaving the factory.

Company Vision

Become a leading scientific and technological innovation pharmaceutical enterprise

The company has always adhered to the scientific development concept to guide the overall situation, product innovation as the driving force, R & D center as the starting point, and sales as the leader. With the continuous enhancement of independent innovation capabilities, it has formed a "listed generation, storage generation, and R & D generation". Benign pattern. In the future development, Yumankun will continue to "patient-centered and clinical value-oriented" as the goal, while innovating technological paths and business models, driving the transformation and upgrading of product research and development, production technology and marketing models, and becoming innovative and international The pharmaceutical group of China has made steady progress and made new and greater contributions to the development of my country's pharmaceutical industry.